Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: j_fir2 who wrote (2322)	4/15/1999 11:36:00 AM
From: Don Miller	Read Replies (1) \| Respond to of 10280

OT sorry for butting in but, there would be more money for shares if those verbal images were converted to pictures and the pictures were sold. millerd1

To: j_fir2 who wrote (2322)	4/15/1999 12:03:00 PM
From: Biomaven	Read Replies (2) \| Respond to of 10280

j fir2: Are you a little concerned that it might be problems with the Allegra patent interference matter? I'd rather not see anything undermine SEPR's bold business plan I'd just like to emphasize that even if SEPR lost the interference proceeding (something about which I've heard absolutely nothing), it would have no impact on the overall business plan. The issue in the proceeding is simply who invented what first, not whether the improvement is patentable. Losing this would have no impact on SEPR's basic strategy - it would just say that in this one case they didn't get there first. Royalties are low and not due for a couple of years anyhow, so the fiscal impact wouldn't be real significant either. Peter